Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer.
Murakami J, Asaumi J, Kawai N, Tsujigiwa H, Yanagi Y, Nagatsuka H, Inoue T, Kokeguchi S, Kawasaki S, Kuroda M, Tanaka N, Matsubara N, Kishi K.
Murakami J, et al. Among authors: inoue t.
Cancer Chemother Pharmacol. 2005 Jul;56(1):22-8. doi: 10.1007/s00280-004-0976-x. Epub 2005 Mar 25.
Cancer Chemother Pharmacol. 2005.
PMID: 15791453